Publications

Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial

Feb 1, 2018

Oxidative Stress and Cardiovascular Risk in Type 1 Diabetes Mellitus: Insights From the DCCT/EDIC Study

May 15, 2018

Comparison of Surgical and Medical Therapy for Type 2 Diabetes in Severely Obese Adolescents

Mar 12, 2018

Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 Diabetes

2018

Impact of Insulin and Metformin Versus Metformin Alone on beta-Cell Function in Youth With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes

1-Aug 2018

Labor induction versus expectant management in low-risk nulliparous women

2018

Menstrual Dysfunction in Girls From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study

Jun 2018

Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease

Jan 9, 2018

Depressive symptoms and glycemic control in youth with type 2 diabetes participating in the TODAY clinical trial

Jan 2018

Intrapartum fetal heart rate tracing among small-for-gestational age compared with appropriate-for-gestational-age neonates

2018

Increased Plasma Levels of Select Deoxy-ceramide and Ceramide Species are Associated with Increased Odds of Diabetic Neuropathy in Type 1 Diabetes: A Pilot Study

Mar 2017

Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study

2-Aug 2017